As CSCs are considered to be responsible for drug resistance in many cancer types including PCa, this study aimed to examine whether TKI treatment targeting FGFR would show signs of drug resistance suggested via ALDH7A1 expression. This evidence concerns the gene ALDH7A1 and cancer.